Author's replyBMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7043.1417c (Published 01 June 1996) Cite this as: BMJ 1996;312:1417
- Maurice L Slevin
- Medical oncologist St Bartholomew's Hospital, Department of Medical Oncology, London EC1A 7BE
EDITOR,—Richard Gray and John Northover criticise my editorial on the grounds that I reviewed the literature selectively. In fact, I reviewed all the available literature on trials of adjuvant chemotherapy in Dukes's type C colon cancer, either published or available as an abstract, since Laurie et al's publication of 19891 and did not apply any selection. The trials that Gray and Northover quote (N Wilking, Stockholm colorectal cancer symposium, Stockholm, 12-13 Oct 1995)2 are in progress and therefore cannot be reviewed.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial